Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8307985

EMD:Ref Document

Bid Value: Ref Document

446 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brinzolamide Brimonidine Atr

Deadline: 10 May 2026

Germany

Ref. No.: 8307469

EMD:Ref Document

Bid Value: Ref Document

211 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8305975

EMD:Ref Document

Bid Value: Ref Document

303 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pomalidomide

Deadline: 10 May 2026

Germany

Ref. No.: 8305884

EMD:Ref Document

Bid Value: Ref Document

211 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bosutinib

Deadline: 10 May 2026

Germany

Ref. No.: 8305728

EMD:Ref Document

Bid Value: Ref Document

211 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Brinzolamide Brimonidine Official Atc Code S01Ec24

Deadline: 31 Oct 2025

Germany

Ref. No.: 8302226

EMD:Ref Document

Bid Value: Ref Document

20 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8238031

EMD:Ref Document

Bid Value: Ref Document

446 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8229694

EMD:Ref Document

Bid Value: Ref Document

446 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8222586

EMD:Ref Document

Bid Value: Ref Document

446 Days Left

59 Heat Sink Electrica

Deadline: 26 Aug 2026

United States

Ref. No.: 8194552

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8162291

EMD:Ref Document

Bid Value: Ref Document

446 Days Left

Forest Improvement Herbicide Fort Drum

Deadline: 22 Aug 2029

United States

Ref. No.: 8120353

EMD:Ref Document

Bid Value: Ref Document

1411 Days Left

Delivery Of Medical Devices For The Needs Of Dr Tota Venkova Medical Center Jsc Gabrovo

Deadline: 21 Aug 2027

Bulgaria

Ref. No.: 8099136

EMD:Ref Document

Bid Value: Ref Document

679 Days Left

Medicines Containing The Active Ingredient Dapagliflozin Atc A10Bk01

Deadline: 31 Jul 2026

Germany

Ref. No.: 8054393

EMD:Ref Document

Bid Value: Ref Document

293 Days Left

Provision Of Weather Monitoring Sensors And Access To Third Party Data

Deadline: 31 May 2030

Great Britain

Ref. No.: 8052462

EMD:Ref Document

Bid Value: Ref Document

1693 Days Left

Discover Tenders by Access Gates Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Access Gates Sector

Filter Your Search

FREE Trial plan for all new users!